CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | French Glendon E. III President and CEO | Sale | −1,711 | $11.03 | $19K | 1,032,580 |
| 2023-03-01 | French Glendon E. III President and CEO | Grant or award | +173,500 | 1,206,080 | ||
| 2023-03-01 | French Glendon E. III President and CEO | Grant or award · Employee Stock Option (right to buy) | +356,300 | 356,300 | ||
| 2022-12-01 | French Glendon E. III President and CEO | Sale | −1,436 | $5.93 | $9K | 1,036,508 |
| 2022-12-01 | French Glendon E. III President and CEO | Sale | −2,195 | $5.93 | $13K | 1,034,313 |
| 2022-12-01 | Lehman David Aaron General Counsel | Sale | −387 | $5.93 | $2K | 44,842 |
| 2022-12-01 | Lehman David Aaron General Counsel | Sale | −682 | $5.93 | $4K | 44,160 |
| 2022-12-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −382 | $5.93 | $2K | 181,710 |
| 2022-12-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −673 | $5.93 | $4K | 181,037 |
| 2022-12-01 | Sung Derrick Chief Financial Officer | Sale | −387 | $5.93 | $2K | 263,428 |
| 2022-12-01 | Sung Derrick Chief Financial Officer | Sale | −682 | $5.93 | $4K | 262,746 |
| 2022-11-29 | Lynch Alissa Hsu Director | Purchase | +1,700 | $5.51 | $9K | 11,910 |
| 2022-11-14 | Sung Derrick Chief Financial Officer | Exercise or conversion | +10,000 | $2.20 | $22K | 263,815 |
| 2022-11-14 | Sung Derrick Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 5,000 | ||
| 2022-11-14 | French Glendon E. III President and CEO | Exercise or conversion | +10,000 | $2.20 | $22K | 1,037,944 |
| 2022-11-14 | French Glendon E. III President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 156,249 | ||
| 2022-11-08 | Ferrari Richard Director | Purchase | +5,338 | $5.31 | $28K | 29,935 |
| 2022-11-08 | Ferrari Richard Director | Purchase | +100 | $5.29 | $529 | 30,035 |
| 2022-09-15 | French Glendon E. III President and CEO | Sale | −25,000 | $20.00 | $500K | 1,027,944 |
| 2022-09-01 | Sung Derrick Chief Financial Officer | Sale | −392 | $17.87 | $7K | 254,505 |
Page 14 of 23 · 450 trades